Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Cancel cervical cancer – In conversation with Brazil, Colombia and Uruguay experts
Despite being highly preventable, the Pan American Health Organization estimates cervical cancer kills 35,700 women…
Policies favouring high-volume hospitals may disadvantage rural cancer patients
Patients with cancer who live in rural Pennsylvania counties appear to know that they may…
How naked mole rats resist aging
Heterocephalus glaber or naked mole-rats (NMRs)—a mammal species native to Eastern Africa—are the longest-living rodents with…
SABCS 2023: PROSPECT trial results – Less treatment, fewer side effects and reduced costs to the health system
- SABCS 2023: Tucatinib plus trastuzumab emtansine may benefit patients with advanced or metastatic HER2-positive breast cancer
- SABCS 2023: Exercise may boost quality of life for patients with metastatic breast cancer
- Blood hormone levels identify which post-menopausal women will benefit most from a medication to prevent breast cancer
Genomic comparison of prostate cancer cells eradicated by and resistant to treatment allows researchers to identify targets for enhanced therapy
- ESMO 2021: ARCHES study finds enzalutamide reduced risk of death by 34% in men with metastatic hormone-sensitive prostate cancer
- Australian trial first to demonstrate preserved quality of life in curative radiation therapy for early recurrent prostate cancer
- Shorter course of radiotherapy safely delivers treatment for prostate cancer
New ‘chemical weapon’ for cancer
The fight against cancer involves eradicating cancer cells but current treatments inevitably have negative consequences on healthy cells. Patients often…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.